Related Experiment Video
Updated: Aug 18, 2026

16:24
Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
Estrogen receptor protein in breast cancer as a predictor of recurrence
Cancer
|May 15, 1981
Abstract:
Estrogen receptor protein (ERP) determinations of primary cancers of 1034 patients with primary breast cancer were done. ERP-positive patients tended to have a lower recurrence rate and had significantly improved survival. This difference was most apparent in patients with four or more axillary nodes involved. ERP-positive patients who recurred had a better survival. ERP did not influence response that adjuvant chemotherapy, nor did the presence of progesterone receptor or femtomole level of ERP affect recurrence.

